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Abstract
This paper investigates socioeconomic determinants of outpatient antibiotic
consumption in Europe. Comparable data on antibiotic use measured in the
defined daily doses per 1000 inhabitants (DID) are currently provided by the
ESAC project. Results from applied econometric estimations for panel data re-
veal a link between antibiotic use and the per capita income, the demographic
structure of the population, the level of education and cultural aspects. Supply-
side factors, such as the density of providers and their remuneration methods,
are also considered. We provide the first estimate of the impact of bacterial
resistance on consumption when the eﬀect of other determinants is simultane-
ously taken into account.
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1 Introduction
Antibiotics have significantly contributed to the reduction in the likelihood of dying
from infectious diseases worldwide (WHO, 2000; 2001). However, researchers have
suggested that almost one third of drug prescriptions are questionable (Wise et al.,
1998; Homer et al., 2000). Indeed, multiple imperfections characterize the market for
antibiotic treatment. First, consumers may have the incentive to purchase more drugs
than they would if insurance coverage was not available (Newhouse, 1993). Studies
have shown that under time pressure doctors tend to satisfy their patients and to
avoid follow up visits by prescribing more antibiotics (Butler et al., 1998). Second,
the inappropriate use of antibiotics may be due to patients’ lack of information.
The individual’s marginal benefit from consumption does not consider the external
benefit derived from one’s treatment with antibiotics which reduces the probability
of infection spreading to other individuals (Elbasha, 2003). Finally, the misuse of
antibiotics may contribute to the selection of resistant bacteria. This leads to the
production of newer and more eﬀective generations of drugs, thus raising the costs
for society (Coast et al., 1998; McGowan, 2001; Levy, 1998).
During the 80s most European countries experienced a remarkable increase in the
number of antibiotic prescriptions. According to Davey (1996) a partial explanation
is represented by the increasing use of antibiotics for respiratory symptoms. Although
antibiotic prescriptions have slightly decreased during the 90s and been roughly stable
in recent years, prescribing practices still vary widely across countries (Elseviers et al.
2007). Consequently, the investigation of cross-country diﬀerences may contribute to
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the debate on appropriate antibiotic use through the understanding of determinants
of consumption.
The European Surveillance of Antimicrobial Consumption (ESAC) project has
been collecting comparable data on outpatient antibiotic use across European coun-
tries since 1997. Preliminary investigations have shown the presence of clusters of
consumption across Europe and an association with bacterial resistance (Goossens et
al. 2005). To our knowledge there are no rigorous multifactorial analysis of determi-
nants of antibiotic use. Previous studies on socioeconomic determinants have rather
focused on regional variations within a country (Filippini et al., 2006; Bremon et al.,
2000).
Diﬀerences in antibiotic use across geographical areas may be explained by demo-
graphic, cultural, and economic factors capturing consumer’s behaviour. Moreover,
supply-side factors such as the density of doctors and their remuneration system may
also have an impact on consumption. This paper proposes an approach to the study of
determinants of outpatient antibiotic use in Europe based on multivariate economet-
ric techniques. The interaction between determinants of consumption is taken into
account and the impact of each single determinant is assessed. This allows for a more
precise investigation of the association between bacterial resistance and consumption
compared to previous studies.
The paper is organized as follows. In section 2 we summarize data on cross-
country variations in outpatient antibiotic use in Europe. In section 3 we discuss
potential determinants and present some summary statistics. A simple econometric
model of antibiotic use is sketched in section 4. Estimation results are analysed in
3
section 5. Section 6 concludes.
2 Variations across Europe
Outpatient antibiotic utilization across European countries can be compared in terms
of defined daily doses (DDD) per 1000 inhabitants per day (DID)1. The European
Surveillance of Antimicrobial Consumption (ESAC) project collected data on an-
tibiotic use from national databases using either reimbursement or distribution/sales
data. Antibiotic sales, prescribing and consumption are sometimes used interchange-
ably in the European study although concepts are not exactly the same. Patients
may systematically lack compliance either because they badly tolerate the treat-
ment or because symptoms have resolved. Moreover, as suggested by Cizman (2003),
physicians may overprescribe antibiotics to meet patient’s expectations or to reduce
misdiagnosis of bacterial infections. On the other hand, prescribing data may also
underestimate consumption since antibiotics purchased over the counter are not in-
cluded. As for wholesales to dispensing pharmacies, doctors and drugstores, these
may not match prescribing data if drugs can also be purchased without any pre-
scription. This is illegal in the EU, but happens in southern Europe. A mismatch
between wholesales and prescribing data may also derive from seasonal fluctuations of
retailers’ stocks of drugs due, for instance, to unexpected variations in the incidence
of infections. We hypothesize that possible mismatches between antibiotic sales and
antibiotic prescribing can be ignored and, consequently, we use either one term or
the other interchangeably.
1The defined daily dose (DDD) is based upon the WHO version 2004.
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Figure 1: Variations in outpatient antibiotic use across Europe by year.
We summarize outpatient antibiotic use for 21 European countries participating
in the ESAC project and able to provide comparable and reliable data for at least 7
years since 1997. As shown in figure 1 use has been roughly stable between 1997 and
2004. However, large diﬀerences are observed across countries (Ferech et al., 2006).
Relatively high use is registered in France, Greece, and Spain, among others (figure
2). On the other hand, Austria, Denmark, and the Netherlands, for instance, exhibit
significantly lower values. The mean consumption between 1997 and 2004 has been
20.34 DID with a peak in 1999 (21.15 DID) and a minimum in 2004 (19.43 DID).
Elseviers et al. (2007) showed that there are substantial regional diﬀerences in use
when European countries are clustered into 3 main groups (East, North and South).
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In table 1 we consider a more detailed clustering and classify countries in 4 groups
(East, North, South andWest). Countries in the western group (19.97 DID) generally
consume more antibiotics than northern countries (16.86 DID) and less than eastern
countries (20.96 DID). These diﬀerences could suggest that cultural aspects/patients’
preferences can at least partially explain variations in antibiotic use across European
countries. Nevertheless, the eﬀect of these aspects can only be ascertained when
supply-side factors are simultaneusly taken into account.
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Figure 2: Outpatient antibiotic use in Europe by country and year.
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3 Determinants
Cross-country variations in antibiotic consumption in the community can be ex-
plained by a variety of factors. Harbarth et al. (2002) suggested that large diﬀerences
in antibiotic consumption between France and Germany may be partially associated
to risk factors in the incidence of infections., i.e. diﬀerences in the concentration of
child care facilities and in the breast feeding practices between the two countries.
However, the diﬀerence in the incidence of bacterial infections can hardly explain
variations in the use of antibiotics as large as three fold among European countries.
The literature has mentioned the lack of education, physicians and patients’ expec-
tations, uncertainty, cultural and social behavior, and diﬀerences in regulatory prac-
tices, among other factors (Belongia and Schwatz, 1998; Finch et al. 2004). Hence,
patients’ preferences and doctors’ incentives to prescribe may play an important role
in explaining the use of antibiotics across Europe.
Country Mean DID (1997-2004) Country Mean DID (1997-2004)
Austria 12.39 Denmark 12.89
Luxemburg 25.96 Finland 18.59
The Netherlands 9.94 Iceland 21.28
Belgium 24.74 Ireland 19.12
Germany 13.95 Norway 15.66
France 31.87 Sweden 15.28
United Kingdom 15.02
West 19.97 North 16.86
Czech Republic 17.65 Greece 29.04
Hungary 19.40 Italy 24.75
Poland 21.30 Portugal 24.94
Slovakia 26.22 Spain 28.32
East 20.96 South 26.97
Table 1: European outpatient antibiotic use by country and regions.
Previous studies focusing on specific determinants of antibiotic use have been
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conducted either in the form of trials or questionnaire surveys. Macfarlane et al.
(2002), for instance, investigated the impact of patient’s information and showed
that the distribution of information leaflets may eﬀectively reduce the use of an-
tibiotics without aﬀecting the doctor-patient relationship. This advocates the role
played by supply-side factors, such as doctors’ attitudes towards antibiotic prescrip-
tions, when patients lack information. Unsworth and Walley (2001) revealed that
antibiotic prescribing is related to practice characteristics in the British NHS. De-
prived and single-handed practices tend to prescribe more but cheaper antibiotics,
while dispensers and trainers with low level of deprivation and early wave fundholders
have lower rate of prescriptions. The result indicates that doctors are sensitive to eco-
nomic incentives. Consequently, under imperfect information a higher concentration
of practices may result in a higher number of prescriptions per capita if doctors are
profit maximizers. The eﬀect may be even stronger under a fee-for-service payment
system, since marginal gains are directly related to the amount of services provided.
Conversely, under a capitation contract, doctors’ remuneration is based upon the
number of patients cured and the link with the number of prescriptions may be less
important.
Patients’ preferences may also play a significant role. Cockburn and Pit (1997)
assert that doctors may be prone to pleasing patients. Patients expecting a medi-
cation are nearly three times more likely to receive it compared to other patients.
Moreover, patients are ten times more likely to receive a medication if practitioners
perceive a patient’s expectation on prescribing.
Antibiotic prescribing are expected to be related to the demographic structure of
8
the population. Resi et al. (2003) found that the percentage of children receiving
antibiotics decreases as they grow up. Focusing on provincial governments in Canada,
Di Matteo and Grootendorst (2002) have shown that drug expenditure increases as
the population ages.
Finally, diﬀerences in levels of bacterial resistance across countries may aﬀect the
use of antibiotics. The knowledge of overall levels of bacterial resistance within a
country is likely to be shared by health care providers after some time. Therefore,
prescribing strategies are expected to change and to include more recent generations
of antibiotics. In that sense, antibiotic resistance will drive prescribing of new, broad-
spectrum antibiotics. Although resistance is primarily caused by increasing antibiotic
use, the following increase in broad spectrum antibiotics is a secondary and perhaps
relevant eﬀect. A positive correlation between antibiotic use and bacterial resistance
in Europe has been recently alleged by Goossens et al. (2005). Although the corre-
lation is evident, the impact of bacterial resistance can only be assessed when other
determinants of consumption are simultaneously considered. The proposed model in
section 4 will address this point.
3.1 Data
Annual data available on determinants of outpatient antibiotic use between 1997
and 2004 are summarized in table 2. These include socioeconomic characteristics
of the population (income, demographic structure, education and cultural/regional
clusters), supply-side factors (density of doctors and the system of remuneration) and
levels of bacterial resistance.
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Data were obtained from a variety of sources. Information on per capita income,
density of physicians, and the level of education (attainment of ISCED 5A/6) were
extracted from publications by the OECD (OECD Health Data, 2006). The de-
mographic structure of the population was derived from Eurostat tables (Eurostat,
2006). Looking at yearly country profiles published by the European Observatory
on Health Systems and Policies (2006) we collected information on the main type
of payment system on hold for general practitioners (fee-for-service, capitation and
salary).
As for the levels of bacterial resistance, data were obtained from the European
Surveillance on Antimicrobial Resistance database (EARSS, 2006). Routine antimi-
crobial susceptibility tests on invasive isolates of Streptococcus pneumoniae are col-
lected by participating laboratories in each country and submitted to EARSS. We
neglect possible bias in the comparison of susceptibility data between countries that
may be due to diﬀerences in case mix and hospital specialities or may be introduced
as a result of diﬀerent laboratory routines between countries.
Data for all variables were generally available for 8 years, with the exception of
bacterial resistance whose systematic collection across European countries started
more recently (from 1999/2000).
4 The model
Our approach to the investigation of determinants of antibiotic consumption is to use
European consumption data and regress them against a set of variables suggested by
the literature as plausible causal factors of the demand for drugs. This method is
10
Description Variables Mean Std. Dev. Min. Max.
Outpatient antibiotic DDDs per 1000 inhab. 20.34 6.25 9.75 34.33
consumption per day (DID)
Income per capita GDP in PPP/pop. (Y) 24800 9302 8759 63453
Demographic structure Pop. under 14/pop. (POP1) 18.02 2.25 14.1 24
of population Pop. 15-24/pop. (POP2) 13.47 1.92 10.6 17.5
Pop. 25-64/pop. (POP3) 53.57 1.96 47.9 57.2
Pop. 65-79/pop. (POP4) 11.53 1.47 8.5 14.6
Pop. over 80/pop. (POP5) 3.41 0.79 1.8 5.3
Attainment of high Pop. with ISCED 5A/6 over 14.37 4.97 5.9 29.4
education total pop. (EDU)
Density of doctors Nr./1000 inhab. (DPH) 3.11 0.61 1.9 4.9
Bacterial resistance Nr. PNSP isolates/tested isolates 11.31 11.13 0 48
(RES)
GPs reimbursement Fee-for service (PGP1 = 1)
Capitation
Salary (PGP2 = 1)
Cultural aspects West
(regional clusters) East (REGe = 1)
North (REGn = 1)
South (REGs = 1)
Table 2: Variables notation and summary statistics
applied, for instance, by Di Matteo (2005) to investigate the macro determinants of
health expenditure in the United States and Canada and by Filippini et al. (2006)
to study regional variations in the use of antibiotics in Switzerland.
We specify an ad-hoc demand function for antibiotics used in outpatient care
in Europe. The demand for antibiotics depends on the individual’s stock of health
care, income, the level of bacterial resistance, and other socioeconomic variables such
as age, education, and cultural attitudes towards the use of drugs.2 Socioeconomic
variables are usually included in the model as proxies for the individual stock of
health care, which is diﬃcult to measure. Moreover, the demand for antibiotics could
2The use of aggregated data to explain individual antibiotics consumption implies the assumption
that the hypothesized relationship between the economic variables used is homogeneous across all
individuals. Therefore, by using aggregate data at a national level we could encounter an aggregation
bias.
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also depend on some characteristics of the supply of health care services, such as
physicians’ density or the physicians’ remuneration system. Antibiotics are usually
purchased under doctors’ prescriptions and fully reimbursed by the NHS or social
insurances; hence, we neglect antibiotic price.
We specify the following parsimonious empirical model for the per capita demand
of outpatient antibiotics:
DIDit = f(Yit, DPHit, POPjit, EDUit, PGPkit, REGhi, RESit−1), (1)
where DIDit are per capita antibiotic sales in country i and year t, measured in
defined daily doses, Yit is the per capita national income, DPHi is the physicians’
density, POP1it .. POP5it indicate the percentage of the population below 14, between
15 and 24, 25 and 64, 65 and 79, and over 80. EDUit is the percentage of individu-
als with graduate education (ISCED 5A/6). The remuneration system for general
practitioners is taken into account by two variables: PGP1it and PGP2it. PGP1it is
equal to 1 if doctors are paid a fee per service provided, and 0 otherwise. Instead, if
doctors work under a salary regime PGP2it is 1, otherwise 0. Consequently, the cap-
itation contract represents the system for comparison. A “cultural” or geographical
dummy (REGhi) that takes into account similarities with adjacent countries and cul-
tural diﬀerences across Europe is also included. Lecomte and Paris (1994) suggested
that socio-cultural factors which are hard to measure might explain diﬀerences in
consumption patterns between European countries. We divided countries into four
groups: “North” (REGni = 1), “South” (REGsi = 1), “East” (REGei = 1), and
“West”, i.e. the reference group. Finally, RESit−1 measures the rate of bacterial
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resistance. The hypothesis that the impact of baterial resistance on antibiotic use
is instantaneous is not very realistic. More plausibly, the information on levels of
bacterial resistance within a country spreads among decision makers with a time lag.
Prescribing strategies may be updated over time when new data are available. We
assume that antibiotic consumption in the current period (t) is aﬀected by levels of
bacterial resistance established during the previous period (t− 1).
The estimation of equation 1 requires the specification of a functional form. Sev-
eral alternative forms could be considered since the theory of demand is quite am-
biguous regarding this issue. Generally, the log-log specification oﬀers an appropriate
functional form for investigating the responsiveness of antibiotic sales to changes in
explanatory variables. The major advantage is that the estimated coeﬃcients can
be interpreted as elasticities3, which are, therefore, assumed to be constant. How-
ever, the log transformation has not been applied to the demographic structure of
the population, education, and the level of bacterial resistance since they are de-
fined as percentage ratios. Thus, we are using a hybrid log-log functional form. The
functional specification can then be written as:
lnDIDit = β0 + β1 lnYit + β2 lnDPHit +
6X
j=3
βjPOPjit + β7EDUit+
+
9X
k=8
βkPGPkit +
12X
h=10
βhREGhi + β13RESit−1 + νi + εit, (2)
where ln() is a natural logarithm applied to the variable and νi and εit are error terms
with standard distribution assumptions. The inclusion of lagged values for bacterial
3This means that coeﬃcients represent the percentage change in the value of the explained
variable corresponding to a one percent variation in the value of the explanatory variable.
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resistance restricts the number of observations available for the estimation to 79.
With regard to the choice of the econometric technique, it should be noted that
in the econometric literature we can find various types of models focusing on cross-
sectional variation, i.e. heterogeneity across units. The three most widely used
approaches are: the fixed-eﬀects model, the random eﬀects model and the Kmenta
model.4 In order to choose the econometric approach it is important to consider that
our dataset is a panel characterized by a relatively small number of time periods as
well a relatively small number of cross-sectional units. Moreover, the within variation
of the majority of the variables included in the model is relatively low. In this case,
as suggested by Cameron and Trivedi (2005), the use of the fixed eﬀects model could
imply a low statistical eﬃciency of the estimated parameters. Therefore, the following
comments are based on the results obtained with a random eﬀects model (Model 1 )
and with a Kmenta model (Model 2 ).5 Moreover, for comparison purposes we present
also the estimation results obtained using OLS.
Estimations have been carried out using the econometric software STATA (version
9). We discuss our findings in the following section.
4For a detailed presentation of the econometric methods that have been used to analyze panel
data, see Greene (2003) and Baltagi (2001). The Kmenta approach is also technically known as the
cross-sectionally heteroskedastic and timewise autoregressive model (Kmenta, 1986). This approach
is attractive when N , the number of units, is lower than T , the number of periods, or when the
within variation of many explanatory variables is very low.
5In the Kmenta model we consider the heteroschedasticity and time-wise autocorrelation of the
error terms.
14
5 Results
The parameter estimates of the three models are summarized in table 3. The results
are satisfactory and stable over the three models. The level and number of significant
coeﬃcients in the random eﬀects model is slightly less than in the other two models.
This diﬀerence could be due to the low within variation of the variables. However, no
structural diﬀerence in the results is observed. Therefore, the impact of the diﬀerent
explanatory variables on the per capita antibiotic consumption is based on all three
models.
The coeﬃcient of income is always very significant and shows a positive sign. This
suggests that richer countries generally use more outpatient antibiotics compared to
lower-income countries. Since per capita antibiotic doses and regressors are in log-
arithmic form, the coeﬃcients can be interpreted as elasticities. The responsiveness
of the per capita outpatient antibiotic use to a 1% change in the average national
income, ceteris paribus, is between 0.37% and 0.68%. The result conjectures that
antimicrobials may not be as strongly normal goods as argued by Baye et al. (1997),
whose calculated income elasticity was 1.331 and is in accordance with previous find-
ings on regional Swiss data analysed by Filippini et al. (2006). Since Baye et al. focus
on USA data, our finding may then denote that the European population is less keen
on consuming antibiotics when income increases or is more likely to substitute antibi-
otics with alternative treatments. Also, note that Baye et al.’s study is based upon
1984-1990 data. The raising concern on the impact of antibiotic resistance over the
90s may have reduced income elasticity of outpatient antibiotic expenditure over time
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thus leading to lower elasticity values. Indeed, the coeﬃcient on time trend does not
show any significant increase in the use of antibiotics between 1997 and 2004.
Model 1: OLS Model 2: GLS Model 3: GLS
AR(1) Random-eﬀects
Obs. 79 Obs. 79 Obs. 79
Adj. R2 0.9334 Wald χ2 (14) 1364.47d Wald χ2 (14) 163.23d
Log likelihood 113.3498 R2(overall) 0.8867
Variables Coeﬀ. Std. Err. Coeﬀ. Std. Err. Coeﬀ. Std. Err.
Constant -8.234648d 1.148146 -7.283572d 1.03831 -2.711372 1.812378
lnY .681311d .0789913 .5741782d .070008 .3697206c .1361809
POP1 .0525683c .0164403 .0623434d .0162189 .0415756 .0281299
POP2 .0688822c .0190896 .0666265d .0175879 .0043953 .02419
POP4 .1951813d .0235587 .1934276d .01931 .0792842b .0359754
POP5 -.1557526d .0358406 -.1476135d .0320138 -.1293506b .0582641
EDU -.0111827d .0029492 -.0131378d .0024642 -.0142094c .0052054
REGe .4170515d .0678572 .4186644d .0672672 .3344426b .1361288
REGn .286858d .0634562 .2822059d .0608847 .2087966b .1058358
REGs .3172736d .0523735 .3566177d .05231 .415573d .1032227
lnDPH .3281048c .097591 .2790845c .0818382 .3160585a .1616467
PGP1 .1791297d .0395915 .2200967d .0299377 .2281424c .0620284
PGP2 .127164d .0309736 .1177165d .027197 .1505106b .0620284
t .0055566 .009082 .0189277c .0065225 .0071173 .010927
RES .0113529d .0018655 .0101437d .001546 .0102264d .0024806
σκ = .0536263
σε = .04383086
ρ = .59950498
a significant at 10%, b significant at 5%, c significant at 1%, d significant at 0.1%,
Table 3: Parameter estimates for the three models.
The level of education is negatively related to the per capita outpatient antibiotic
expenditure defined in DID and is highly significant. It shows that an increase in the
percentage of people with higher education reduces the individual consumption of an-
tibiotics. Education elasticities are close to zero in all the estimations. The outcome
advances that countries with a higher proportion of highly educated people use an-
tibiotics more eﬃciently, ceteris paribus. To our knowledge, there are no comparable
multivariate studies on the impact of education on the use of antibiotics. A com-
parison with the literature on medical care utilization, such as physician oﬃce visits
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or hospital services, suggests that antibiotics are quite peculiar. Hunt-McCool et al.
(1994) found positive education elasticity to physician oﬃce visits and hospital care,
although the impact is not very significant. In the case of antibiotics in outpatient
care the possible link between increasing consumption and the reduced eﬀectiveness
due to bacterial resistance may induce more educated individuals to restrain from
antibiotic utilization. Another explanation is that more educated individuals show
better compliance with antibiotic treatment, hence a lower amount of antibiotic doses
is required for eﬀective care, ceteris paribus.
The eﬀects of diﬀerent classes of age on antibiotic sales are captured by covariates
POP1−POP5. It is worth noticing the impact of children and elderly consumers. One
may expect that antibiotic use is higher for young people since doctors and patients
are likely to reduce the risk of bacterial infections under uncertainty. For similar
reasons, antibiotic consumption may be higher for elderly people. Accordingly, our
estimations show positive and significant coeﬃcients of the proportion of individuals
below 25 in the OLS and the Kmenta models.6 We also found a positive impact of
the proportion of the population between 65 and 79 in the three models. Indeed,
the literature on determinants of health care expenditure generally suggests that the
increasing prevalence of chronic health problems as people grow older may determine
an increase in the utilization of health care services. However, this may not hold for
antibiotics in the same extent. Di Matteo and Grootendorst (1998) found a slightly
significant increase in drug expenditure in the population between 64 and 74, although
6Note that DID measures generally underestimate antibiotic use by children. Consequently, the
estimated impact of young consumers could even be stronger.
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the result is not confirmed by the more recent study by Di Matteo (2005). We show
that individuals above 80 seem to reduce the per capita consumption of outpatient
antibiotics. Because of major health problems, one can point out that people in
the last few years of life are more likely to consume antibiotics in nursing homes or
hospital clinics rather than getting them prescribed in outpatient care.
Some countries share cultural characteristics that may shape their attitudes to-
wards the use of antibiotics. Indeed, public perception of the need for antibiotics
and the prescription policy may be aﬀected by cultural identities. These hypothesis
are worth testing also in the light of diﬀerences observed in antibiotic consumption
across regional clusters (Goossens et al., 2005). Cultural covariates introduced in our
models exhibit significant coeﬃcients. They indicate that antibiotic use is higher in
southern and eastern part of Europe (REGs and REGe) compared to western Eu-
ropean countries. This result should generally account for cross-country diﬀerences
in the characterisitics of the demand, hence in patients’ attitude towards antibiotics.
However, it is hard to exclude any dependence between demand and supply, i.e. pa-
tients and doctors, when decisions about consumption are taken. The correlation
between geographical dummies and the density of doctors suggests that higher per
capita antibiotic use in southern countries may not derive from consumers’ attitudes
only.
Note that the coeﬃcient of REGn is positive and theorizes that northern coun-
tries are likely to consume more antibiotics per capita than western countries, ceteris
paribus. This is apparently surprising if compared with the descriptive statistics
above. The reason lies in the interaction with supply-side factors such as the den-
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sity of physicians and the remuneration system for doctors. When the eﬀects of
supply-side variables are not taken into account, the regional dummy REGn is bi-
ased and the negative impact of cultural aspects in northern countries is overesti-
mated. The rationale for lower antibiotic use in norther countries may then be due
to lower physicians’ density and the remuneration to general practitioners mainly
based on capitation, rather than to cultural aspects. Indeed, an increase in the den-
sity of physicians in a country causes an increase in antibiotic DID. The coeﬃcient
of physicians’ density is positive and quite significant. This might put forward some
evidence of supply-induced demand of antibiotic treatment in European countries,
ceteris paribus.
Moreover, physicians’ attitudes toward prescriptions may respond to financial
incentives attached to reimbursement schemes. These widely vary across Europe.
Relatively high levels of consumption may be more likely if physicians are paid under a
fee-for-service scheme compared to a capitation one. We found evidence that countries
with a fee-for-service and a salary schemes are prone to consume more antibiotics
per capita compared to countries adopting a capitation reimbursement. Variables
PGP1 and PGP2 are both positive and significant. This is in accordance with the
theoretical hypothesis on financial incentives under diﬀerent payment schemes for
physicians. Under a fee-for-service, doctors’ revenue is usually related to the amount
of prescriptions. The salary scheme may have similar eﬀects. It can be argued
that salaried practitioners lack of incentives to compete for patients compared to
practitioners under a capitation payment. This could imply that under a capitation
scheme doctors are likely to provide better quality services, hence more appropriate
19
antibiotic treatments.
The association with bacterial resistance (RES) is positive as expected and highly
significant. Higher rates of bacterial resistance are associated with an increase in the
per capita antibiotic use in the following period. The result is confirmed in all the
models. Coeﬃcients are around 0.01 and suggest that the elasticity of antibiotic
use to the number of penicillin non-susceptible Streptococcus pneumonie isolates is
very small. Our findings may be weakened by the use of an indicator specifically
constructed for penicillins (% PNSP). A similar result can be obtained by means of
an alternative indicator, the percentage of MRSA isolates. However, the robustness
is reduced since fewer data are available.
6 Conclusions
Antibiotic consumption is characterized by multiple market imperfections. Above all,
increasing levels of bacterial resistance represent a harmful challenge for the society
(Rudholm, 2002). It has been suggested that higher levels of antibiotic use may be
associated to higher rates of bacterial resistance (Goossens et al., 2005). The bat-
tle against resistance is generally fought with the adoption of additional antibiotic
components, which raises concerns about optimal levels of antibiotic consumption
(Laxminarayan and Weitzman, 2002). The investigation of determinants of antibi-
otic use may represent an important contribution to the discussion about eﬀective
government interventions to induce an eﬃcient use of drugs.
Comparable data on outpatient antibiotic use across European countries have
been recently become available thanks to the European Surveillance of Antimicro-
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bial Consumption (ESAC) network. Also, the quality of national data on bacterial
resistance has been improved by the European Antimicrobial Resistance Surveillance
System (EARSS). This unveiled an opportunity for more accurate investigations of
antibiotic use across Europe.
We have shown that diﬀerences in outpatient antibiotic use across countries can
hardly be explained by epidemiological, demographic and cultural factors only. Supply-
side factors such as the density of doctors and economic incentives attached to the
remuneration system may contribute to the explanation of variations in antibiotic
consumption. The impact of bacterial resistance has been assessed simultaneously
with other determinants.
Econometric estimations indicate that the per capita income, the proportion of
children and the elderly, and cultural attitudes in southern and eastern countries
induce higher levels of antibiotic use. On the other hand, higher levels of education
reduce consumption. Increasing antibiotic use is also associated with a higher density
of doctors and a fee-for-service and salary remuneration. Bacterial resistance has a
positive impact on antibiotic use.
From a biological perspective, antibiotic use will lead to selection and emergence
of antibiotic resistance (Malhotra-Kumar et al., 2007 ). But vice versa, bacterial
resistance will result in (i) increased antibiotic use of the more recently available an-
tibiotics (such as the fluoroquinolones) and/or (ii) increased dosage of the old classes
of antibiotics to overcome resistance against these antibiotics (such as amoxicillin and
amoxicillin/clavulanic acid). The former may have less impact on volume of use be-
cause it reflects the substitution of old by new antibiotics. The latter will result in a
21
substantial increase of the number of DDDs (but not of the number of prescriptions).
Finally, the volume use of antibiotics and proportions of resistance is for the most
part stable. This is not surprising since in absence of national interventions that
would abruptly change the utilisation pattern for an entire country, no trend changes
would be expected. Indeed, mathematical models as well as empirical data suggest
that following a reduction in prescribing, the decay of resistance will typically occur
on a slower time scale then the rise in resistance (Austin et al., 1999) ). Likely, no
decline in resistance may occur even with a significant reduction of certain antibiotic
families which can be attributed to the co-selection of genetically linked resistance
determinants by alternative antibiotic pressure (Enne et al., 2001).
In conclusion, our findings assert that incentives for antibiotic prescribers are in-
deed important sources of variations in antibiotic consumption in outpatient care
across Europe. Next to guidelines on appropriate use of antibiotics and awareness
campaigns, economic incentives may provide opportunities for additional policies in-
struments.
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